In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Looking Ahead To 2012: ACOs Get In Gear, Accelerating The Need to Prove Biopharma Products' Overall Value In Health Care

Executive Summary

Thirty-two "Pioneer" accountable care organizations began operations with the new year.

You may also be interested in...



Pfizer Sales Force “Reset” Recognizes Realities Of ACO World, Exec Says

Drug company sales forces have an opportunity to play a larger role in assisting ACO organizations to achieve their goals, Pfizer’s John Zgombic pointed out, because focusing only on a transactional sale with the physician “is no longer valid.”

Honing In On Value At Citicorp Healthcare Conference

The value of medicine was a key theme at Citigroup’s Global Healthcare conference in New York, where top executives from Bristol, Sanofi, Pfizer and Lilly, including J&J’s CEO Alex Gorsky participated in Q&As with analysts and attendees.

Reimbursement News, In Brief

Updates on Medicare’s ACO program, drug spending trends and Medicare coverage of IVIG.

Related Content

Topics

UsernamePublicRestriction

Register

PS054067

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel